Alimera Sciences (ALIM) Reports In-Line Q3 EPS

Alimera Sciences (NASDAQ: ALIM) reported Q3 EPS of ($0.21), in-line with the analyst estimate of ($0.21). Revenue for the quarter came in at $6.9 million versus the consensus estimate of $6.96 million.

For earnings history and earnings-related data on Alimera Sciences (ALIM) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• SuperCom (SPCB) Tops Q3 EPS by 43c
• Ackman adds Netflix, Visa and Mastercard in portfolio revamp